A wearable that could provide continuous monitoring without that physical burden could fundamentally change how people manage their condition.
At the intersection of consumer technology and chronic illness, Huawei has introduced a smartwatch that attempts something medicine has long sought: reading the body's blood sugar without breaking the skin. The Watch 4 analyzes ten physiological signals to warn wearers of rising glucose risk — not a diagnosis, but a whisper of caution arriving on the wrist. In a world where hundreds of millions live under the daily discipline of diabetes management, even an imperfect early warning could carry profound human weight. The question now belongs to regulators, clinicians, and time.
- Huawei's Watch 4 claims to detect high blood sugar risk in 60 seconds using heart rate and pulse wave data — no needle, no blood, no pain.
- The feature stops short of precise glucose readings, functioning instead as an alert system that nudges wearers toward caution when levels appear to climb.
- Competitors are watching closely: Samsung has not crossed this threshold, and Apple's rival technology using silicon photonics remains locked in development.
- For the millions who endure multiple daily finger pricks, the promise of a wrist-worn alternative is not a convenience — it is a potential liberation from a painful routine.
- Regulatory approval and clinical validation stand between this prototype and genuine medical utility, and Huawei's own framing carefully avoids calling it a replacement for real glucose monitoring.
Huawei has unveiled a feature for its Watch 4 smartwatch that could change the daily reality of blood sugar management: a non-invasive system that assesses hyperglycemia risk by analyzing ten health metrics — including heart rate and pulse wave characteristics — in roughly a minute of wear time.
The company's consumer chief demonstrated the capability on Weibo, showing how the watch functions not as a precise glucose meter but as an early warning system. When blood sugar appears to be rising, the device alerts the wearer and notes that diets heavy in sugar, oil, and fat can accelerate the problem — a nudge toward vigilance rather than a clinical verdict.
The announcement places Huawei ahead of the field in a quiet but consequential race. Samsung's wearables offer ECG and blood oxygen monitoring, but no mainstream smartwatch has yet delivered glucose tracking to consumers. Apple has been pursuing the same goal through silicon photonics and absorption spectroscopy, though that work remains unfinished.
The human stakes are real. Traditional blood glucose testing demands multiple daily finger pricks — a process painful enough that many people test less often than they should, with consequences that compound over time. A wearable capable of frequent, frictionless assessments could meaningfully improve how people manage their condition.
Huawei itself frames the feature cautiously, describing it as supporting "high blood sugar risk assessment research" — language that signals awareness of how far the technology must still travel. For it to become a genuine tool rather than a wellness novelty, it will need to satisfy regulators and survive rigorous clinical scrutiny. If it does, the ripple effects across the wearables industry — and across the lives of hundreds of millions living with diabetes — could be significant.
Huawei has announced a feature for its new Watch 4 smartwatch that could reshape how people monitor their blood sugar without the daily discomfort of finger pricks. The company claims the device can assess the risk of high blood sugar by analyzing ten different health metrics—heart rate, pulse wave characteristics, and others—in roughly a minute of wear time.
Yu Chengdong, Huawei's consumer division chief, demonstrated the capability in a video posted to Weibo, showing how the watch detects what the company calls hyperglycemia risk. The Watch 4 does not deliver precise glucose readings the way a traditional blood glucose meter does. Instead, it functions as an early warning system, alerting the wearer when their blood sugar appears to be climbing into dangerous territory. When triggered, the watch displays a message acknowledging the possibility of short-term blood sugar swings and noting that diets heavy in sugar, oil, and fat can push levels higher, encouraging the wearer to continue monitoring.
The move positions Huawei ahead of competitors in a race to bring non-invasive glucose tracking to mainstream wearables. Samsung's Galaxy Watch 5 and similar devices can already perform electrocardiograms and measure blood oxygen, but none have yet delivered glucose monitoring to consumers. Apple has been working on the same problem, according to reporting by Bloomberg, exploring a combination of silicon photonics and absorption spectroscopy to measure blood sugar levels—technology that remains in development.
For people living with diabetes, the potential significance is substantial. The traditional method of checking blood sugar requires pricking a finger multiple times daily, a process that is painful, inconvenient, and often discourages people from testing as frequently as they should. A wearable that could provide continuous or frequent assessments without that physical burden could fundamentally change how people manage their condition. More frequent monitoring typically leads to better control and fewer dangerous swings in either direction.
Huawei's technology is still early. The company describes it as the industry's first smartwatch supporting high blood sugar risk assessment research, a careful framing that acknowledges the feature is not yet a replacement for clinical glucose monitoring. The real test will come in the hands of regulators and the medical community. For the technology to move beyond a novelty feature to something people with diabetes can actually rely on, it will need to prove both accurate and safe through rigorous testing. Regulatory bodies in major markets will need to approve it before it can be marketed as a genuine health tool rather than a wellness gimmick.
If Huawei's approach proves sound and wins regulatory blessing, it could accelerate Apple's timeline and push the entire wearables industry toward more sophisticated health monitoring. The stakes are high: diabetes affects hundreds of millions of people worldwide, and better tools for managing it could prevent serious complications. But for now, the Watch 4's glucose feature remains a promising prototype waiting to prove itself in the real world.
Notable Quotes
Yu Chengdong claimed the Watch 4 is the industry's first smartwatch that supports high blood sugar risk assessment research— Huawei consumer division chief
The Hearth Conversation Another angle on the story
So Huawei is claiming their watch can measure blood sugar without drawing blood. How does that actually work?
They're not measuring glucose directly the way a meter does. Instead, they're reading ten different health signals—your heart rate, how your pulse wave looks, things like that—and using those as proxies to estimate whether your blood sugar is spiking. It's pattern recognition, not direct measurement.
That sounds like it could be wrong a lot of the time.
It absolutely could be. That's why this is still in early research stages. The watch isn't claiming to give you your exact glucose number. It's saying, "Hey, we think your blood sugar might be getting high." It's a warning system, not a diagnostic tool.
Why does this matter so much for people with diabetes?
Because right now they have to prick their finger multiple times a day. It hurts. It's annoying. So people skip it. If a watch could give them useful information without pain, they'd check more often, and better monitoring means better control of their condition.
But Apple is working on this too, right?
Yes, and they're apparently taking a different technical route—using something called silicon photonics. But they're not there yet. Huawei is claiming they got there first, though "first" here means first to announce it, not first to have something that actually works in the real world.
What has to happen before people can actually use this?
Regulators have to approve it. Doctors have to validate that it's accurate enough to trust. Right now it's a feature on a watch. For it to become a real medical tool, it has to prove itself in testing. That's the hard part.